Maciej Zdunek
Biographic Data
| ID | 8252619 |
|---|---|
| NAME | Maciej Zdunek |
| GIVEN NAMES | Maciej |
| FAMILY NAME | Zdunek |
| SIGNATURE | ZDUNEK M |
| AFFILIATIONS | Medical University of Lodz |
| ORCID | 0000-0001-5519-113X |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
No prominent works on this page.
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
Acute Lymphoblastic Leukemia research (1 work) · Acute Myeloid Leukemia Research (1 work) · Cancer (1 work) · Chronic Lymphocytic Leukemia Research (1 work) · Context (archaeology (1 work) · Family medicine (1 work) · Internal Medicine (1 work) · Intervention (counseling (1 work) · Leukemia (1 work) · Medicine (1 work)